PDF Cover

Magnetoencephalography Market

The market for Magnetoencephalography was estimated at $376 million in 2025; it is anticipated to increase to $538 million by 2030, with projections indicating growth to around $768 million by 2035.

Report ID:DS1801068
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Magnetoencephalography
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Magnetoencephalography Market Outlook

Revenue, 2025

$376M

Forecast, 2035

$768M

CAGR, 2026 - 2035

7.4%

The Magnetoencephalography (MEG) industry revenue is expected to be around $376.2 million in 2026 and expected to showcase growth with 7.4% CAGR between 2026 and 2035. Advanced neuro-diagnostics incorporating magnetoencephalography are proving crucial in the early detection of complex neurological disorders. Medical staff are looking for neuroimaging techniques with high temporal resolution which are non invasive. Growing demand for the technology is driven by factors such as the need for precise pre surgical assessments in epilepsy and other neurological disorders, and the wider clinical adoption of magnetoencephalography. Advanced techniques in functional brain imaging, coupled with substantial investments from the medical and pharmaceutical industries, together with favourable insurance policies and the influence of technological progress, are driving the widespread adoption and placing magnetoencephalography at the centre of the tools used in the study of the function of the brain within the neuroimaging infrastructure used today.

Magnetoencephalography monitors the real time magnetic fields that are produced by neurons by using sensitive magnetic field detectors and a cryogenic cooling system. In doing so, it offers information about the functioning of the brain with a time resolution of one millisecond and can map the entire brain, this it does alongside structural MRI and EEG to form a comprehensive model of brain function. Neurological diagnostic uses comprise the majority of MEG procedures, applications in which 72.3% of total use is found. This is because theses of the equipment enable clinicians to locate the focal point of seizures, to characterise brain functions and guide neurosurgeons during operations. Cryogenic technology coupled with conventional technology now holds the most dominant position in the medical technology landscape, the industry will reach an estimated revenue of $294.19 million by the year 2025. Presently, researchers in the field are continually making advancements in the region's of cryogenics, sensor technologies and software analysis systems. This is in turn allowing the applications of this technology to be applied in an ever increasing number of medical facilities.

Magnetoencephalography market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Magnetoencephalography Market Outlook

Market Key Insights

  • The Magnetoencephalography market is projected to grow from $376.2 million in 2025 to $768 million in 2035. This represents a CAGR of 7.4%, reflecting rising demand across Functional Brain Mapping, Epilepsy, and Autism.

  • The market is characterised by an oligopolistic market structure with only 6 significant players. The dominant players in the market are Compumedics Limited and MEGIN who possess the biggest market share.

  • The U.S. and Japan dominate the MEG market and will experience compound annual growth rates between 4.8% and 7.1% between 2025 and 2030.

  • India, Brazil and South Korea are expected to grow at the highest rate in the emerging markets, with compound annual growth rates between 8.5% and 10.2%.

  • The slow introduction of new developments in software algorithms within key Magnetoencephalography market players is allowing adjacent markets, such as Functional Magnetic Resonance Imaging and Electroencephalography, to improve their penetration in the brain mapping and epilepsy sectors. This trend is predicted to capture $22 million in revenue from the existing Magnetoencephalography market.

  • Between 2025 and 2035, the magnetoencephalography market will be worth $392 million more. Applications associated with the manufacture of this product which involve Epilepsy and Stroke are expected to make up a bigger part of the market.

  • As a result of the potential of magnetoencephalography in aiding medical professionals in imaging brain functions, and the increasing rates of neurological conditions such as Alzheimers disease and Parkinsons disease, a considerable expansion in the magnetoencephalography industry is forecast for the period between 2025 and 2035. The expansion is predicted to be 104%.

meg magnetoencephalography market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Magnetoencephalography - Country Share Analysis

Opportunities in the Magnetoencephalography

Among East Asian academic hospitals, expansion of paediatric neurological departments is also in progress. Nonetheless, patients in these departments have limited access to MEG. Systems of child friendly OPM which use no helmets are suitable for monitoring brain activity when sleeping or playing and are non invasive. This makes them ideal for use in cases of epilepsy or developmental issues in children. This region is predicted to see a growth in its OPM revenue, reaching 142.03 million by 2030 from 82.01 million in 2025 at a compound annual growth rate of 11.61%. In terms of market growth, the OPM systems used for pediatric brain mapping will be the most rapidly increasing application region.

Growth Opportunities in North America and Asia Pacific

In North America the key drivers of the adoption of MEG are advanced clinical protocols for the evaluation of epilepsy surgery and for high resolution brain mapping in neurosurgery. This adoption is furthered by the fact that there are reimbursement policies in place and also because there are numerous hospitals which specialise in neuroimaging. There are significant opportunities in magnetoencephalography by installing this equipment within comprehensive epilepsy monitoring units, autism assessment centres for children and stroke rehabilitation facilities. These are potential opportunities through the use of AI with neurology devices, also the integration with MRI and EEG scans as well as cloud data storage systems. Vendors and regional distributors are fighting for dominance in their sector with the result that manufacturers are having to compete in region's other than hardware, such as workflow centric software and turnkey clinical pathways, as well as offering long term service contracts. Forming alliances with prominent hospital groups and research consortia is also crucial to ensure the implementation of a clinical IT system in several sites and to guarantee that upgrades are rolled out regularly.
In the Asia Pacific market, the growth of magnetoencephalography is driven by the rapid expansion of tertiary hospitals and increased awareness of the need to diagnose epilepsy and autism. Key opportunities in the near term will be found in magnetoencephalography systems optimised for cost which will be used in centres treating a lot of epilepsy cases and in brain mapping labs. Also in centres which are just emerging as places for diagnosing autism in children and in clinical pathways for strokes. Due to a mix of regional price sensitive buyers and global suppliers, it is crucial that manufacturers tailor their products for local markets. They must offer customisable systems, flexible payment options and extensive training to establish standard imaging techniques and clinical expertise in various regions, which in turn helps to secure repeat business and create a need for replacement equipment in the long term.

Market Dynamics and Supply Chain

01

Driver: Widening Clinical Demand and Advancements in Non‑Invasive Neuroimaging Technology

Magnetoencephalography market growth is also being driven by the rising global incidence of neurological disorders and concurrent technological innovation in imaging systems. The increasing burden of conditions such as epilepsy, Alzheimer’s, Parkinson’s and other brain disorders is also expanding the need for precise, non‑invasive diagnostic tools in both clinical and research settings, prompting hospitals and neurology centers to invest in MEG systems for early detection and functional brain assessment. MEG’s ability to map real‑time neuronal activity with high temporal resolution supports complex diagnostics and presurgical planning, especially in epilepsy and brain mapping applications. Simultaneously, continuous advancements such as wearable and portable OPM‑based sensors, improved noise cancellation, AI‑enabled data analytics, and integration with other imaging modalities are also enhancing system performance, reducing infrastructure barriers and broadening clinical utility. These dual factors together increase MEG adoption across broader healthcare and research landscapes. 
A key driver for the Magnetoencephalography market is also the integration of artificial intelligence and machine learning into MEG systems. AI‑powered algorithms significantly improve the accuracy and speed of interpreting complex brain magnetic signal datasets, enabling clinicians and researchers to detect subtle neurological patterns, reduce diagnostic errors and accelerate decision‑making. Machine learning enhances real‑time brain source localization, automates artifact removal and supports predictive analytics for early disease identification. This niche trend not only increases MEG’s diagnostic value, but also strengthens its role in personalized neurology, cognitive research, and advanced neurotechnological applications, fostering broader adoption and market growth.
02

Restraint: High Cost of Equipment and Specialized Infrastructure Limits Adoption and Revenue Growth

The magnetoencephalography market is significantly restrained by the high capital investment required for MEG systems and associated infrastructure, which limits procurement by healthcare and research institutions. Advanced MEG units based on SQUID technology often exceed USD 2–3 million, and require magnetically shielded rooms and cryogenic cooling infrastructure, inflating setup costs. These financial barriers restrict adoption primarily to large academic hospitals and specialized centers, reducing demand in smaller facilities and emerging markets. For example, hospitals with constrained budgets frequently defer MEG purchases in favor of more affordable imaging modalities, directly impacting market revenue and slowing regional expansion. High operational and maintenance costs also deter recurrent investment in upgrades and new systems, keeping overall market growth modest despite clinical demand.
03

Opportunity: Growing demand for portable MEG in European neurotechnology startups developing brain–computer interfaces and Expanding epilepsy surgery planning demand in North American tertiary hospitals using advanced Magnetoencephalography

Companies in Europe which specialise in neurological technology are utilising MEG in order to design the next generation of brain interfaces and digital therapies. Presently the high cost of existing equipment, along with the need for considerable shielding and its fixed installation limit experiments that are cryogenic. The portable and transportable OPM systems are making the site selection and the costs less by streamlining the clinical trials at the multiple locations. This has the potential to attract a customer group in addition to the hospitals. The companies which provide OPM systems are demonstrating the strongest growth patterns worldwide. The companies in Western and Northern Europe that operate in a flexible manner will drive a greater use of compact MEG systems. These will be used for longitudinal brain imaging studies that are functional and applied in real life.
US tertiary hospitals are employing MEG technology to identify the exact part of the brain causing seizures in patients prior to surgery. At present, magnetoencephalography, a form of functional brain imaging, provides the most accurate readings for epilepsy cases; nonetheless, access to this technology is restricted to the most well equipped institutions. Growing demand for cryogenic equipment as reimbursement mechanisms improve and the ageing population increases could see the market size rise from $294.19m in 2025 to $395.55m by 2030. This is particularly evident in epilepsy surgery programmes. Traditional service providers will hold on to the biggest share of the market revenue, with OPM and its upgrades concentrating on satellite locations.
04

Challenge: Limited Skilled Workforce, Complex Data Interpretation and Regulatory Barriers Hinder Market Expansion

A key restraint on magnetoencephalography market growth is the scarcity of qualified personnel combined with the technical complexity of MEG data interpretation and evolving regulatory requirements. Operating MEG systems and accurately interpreting their high‑dimensional datasets demand specialized training in neuroimaging and signal processing, which many institutions lack, leading to underutilization of installed units. This skill gap forces facilities to invest in training or hire scarce experts, increasing operational costs and dampening demand. Additionally, lengthy regulatory approvals and inconsistent reimbursement policies in major markets delay new product launches and constrain clinical usage. For instance, regulatory hurdles in North America and Europe slow the integration of advanced MEG systems into routine diagnostics, impeding market penetration and revenue growth despite clinical advantages over conventional imaging.

Supply Chain Landscape

1

Sensor Component Manufacturing

FieldLine Inc.Ricoh Company Ltd
2

Magnetoencephalography Systems

MEGINCTF MEG Neuro Innovations Inc.Compumedics Limited
3

Clinical Neuroimaging Deployment

MEGINCompumedics LimitedRicoh Company Ltd
4

Brain Mapping Applications

HospitalsAcademic Research CentersNeurology Clinics
Magnetoencephalography - Supply Chain

Use Cases of Magnetoencephalography in Functional Brain Mapping & Epilepsy

Functional Brain Mapping : Magnetoencephalography is widely used for functional brain mapping to non‑invasively record neural magnetic activity with millisecond precision, typically using high‑density SQUID‑based whole‑head systems integrated with EEG for multimodal imaging in research centers and advanced hospitals. MEG helps localize sensory, motor, language, and cognitive areas before surgical or therapeutic planning, offering superior temporal resolution compared to fMRI. Its unique ability to differentiate activity across cortical areas supports neuroscience research and clinical decision‑making. Leading players such as MEGIN and Compumedics provide advanced MEG platforms with high channel counts and noise reduction, enhancing brain mapping accuracy and facilitating adoption in neurodiagnostic and research applications.
Epilepsy : In epilepsy diagnostics and treatment planning, MEG’s non‑invasive SQUID‑based systems are primarily used to detect interictal epileptiform discharges and localize the epileptogenic zone with greater spatial accuracy than scalp EEG, often combined with MRI for presurgical evaluation. Neurologists and neurosurgeons rely on MEG to guide resection while preserving healthy cortex, improving surgical outcomes and seizure freedom rates in drug‑resistant cases. MEG’s high temporal resolution and signal fidelity are distinct advantages for epilepsy focus localization. Top MEG vendors such as MEGIN (Elekta), CTF MEG (Compumedics), and Ricoh deliver clinically validated systems with robust software and support networks across major neurology centers.
Autism : Magnetoencephalography is increasingly applied in autism research to explore atypical neural dynamics, such as altered gamma‑band activity and connectivity patterns, leveraging SQUID‑based MEG’s high temporal and spatial resolution. Clinical researchers and academic neuroscientists use MEG to study sensory processing, social communication networks, and neural oscillatory differences in individuals with autism spectrum disorders, enabling deeper insights into brain function and potential biomarkers. While not yet a standard clinical diagnostic tool for autism, MEG’s sensitivity to subtle functional abnormalities enhances understanding of neural mechanisms underlying developmental disorders. Key players like MEGIN, Compumedics, and emerging OPM‑MEG innovators support research use with flexible platforms and strong analysis toolchains.

Recent Developments

Recent developments in magnetoencephalography reflect a shift toward portable MEG systems and OPM‑based brain imaging, improving accessibility for clinical and research applications. Adoption of advanced non‑invasive diagnostics and AI‑enhanced signal processing is boosting demand for high‑resolution neural mapping and functional connectivity analysis. Traditional SQUID MEG remains vital in epilepsy and cognitive research, while emerging wearable technology expands use cases beyond hospitals. This trend strengthens market growth by lowering costs, enhancing patient comfort, and enabling broader deployment in neurology and neuroscience.

February 2025 : MEGIN partners with MYndspan to bring consumer‑accessible MEG brain scans, expanding clinical and public access beyond traditional research and hospital settings, leveraging MEGIN’s hardware leadership.
June 2025 : Compumedics Limited delivers its Orion LifeSpan MEG with dual‑helmet capability (adult and pediatric) to Tianjin Normal University, marking a major installation and enhancing research/clinical brain imaging offerings.
September 2025 : Cerca Magnetics Limited installs its first OPM‑based MEG scanning system at Trinity College Dublin, supporting advanced neuroscience research and broadening wearable MEG adoption.

Impact of Industry Transitions on the Magnetoencephalography Market

As a core segment of the Medical Device industry, the Magnetoencephalography market develops in line with broader industry shifts. Over recent years, transitions such as Advancements in Software Algorithms and Emergence of Portable MEG Devices have redefined priorities across the Medical Device sector, influencing how the Magnetoencephalography market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Advancements in Software Algorithms

Current magentoencephalography technology employs software which helps in signal processing and decreases background interference but this equipment could be improved through the implementation of better signal processing and noise reduction technology. The delay in the development of new MEG systems provides a market worth $22 million for other neuroimaging modalities like the functional magnetic resonance imaging and electroencephalography technologies. These technologies are especially successful in applications related to epilepsy and brain mapping. Currently hospitals and research establishments are giving clinically validated, algorithm driven technology along with streamlined neurodiagnostic processes priority over all else. As a result, the rate at which these technologies are being incorporated into MEG devices has increased and so has the use of alternative technologies in the field of neuroimaging.
02

Emergence of Portable MEG Devices

The emergence of portable magnetoencephalography devices, particularly those using optically pumped magnetometer technology, is transforming the MEG landscape by making the technique more affordable, accessible, and practical compared to traditional stationary systems that require bulky cryogenics and heavily shielded rooms. Unlike conventional SQUID‑based MEG systems, portable OPM‑MEG units eliminate the need for liquid helium cooling, reduce infrastructure costs, and provide wearable configurations that adapt to different head sizes and allow some subject movement during recordings. This innovation is expanding MEG use beyond large research hospitals into smaller clinics, point-of-care settings, and mobile research environments where dynamic brain activity, such as during naturalistic tasks or extended monitoring, is of interest. Early OPM‑based systems have been successfully applied in epilepsy research and experimental brain-computer interface applications, demonstrating potential for real-time neural monitoring outside specialized facilities. These advances are lowering adoption barriers in neuroscience and clinical diagnostics while creating new opportunities in cognitive research and personalized neurology.